Cenobamate Reduces Focal Seizures in Asian Patients
A study was conducted in China, Japan, and South Korea to evaluate the effectiveness and safety of a medication called cenobamate for adults aged 18 to 70 who have uncontrolled focal seizures.
Discover the latest findings in recent epilepsy research, where we break down complex studies into clear insights. Stay informed about cutting-edge breakthroughs, evolving theories, and advancements shaping our understanding of epilepsy.
A study was conducted in China, Japan, and South Korea to evaluate the effectiveness and safety of a medication called cenobamate for adults aged 18 to 70 who have uncontrolled focal seizures.
This study looked at how to recognize early seizures that can happen after a stroke, focusing on adults who had either an ischemic stroke or a type of bleeding in the brain.
This study looked at epilepsy in people with a rare genetic condition called dentatorubral-pallidoluysian atrophy (DRPLA).
Researchers studied a rare condition called Pyridoxine-Dependent Epilepsy (PDE), which is caused by changes in a gene known as ALDH7A1.
Researchers studied the use of stereoelectroencephalography (SEEG) in patients with drug-resistant focal epilepsy.
Researchers studied two methods used to monitor brain activity in people with epilepsy: stereoelectroencephalography (SEEG) and subdural electrodes (SDE).
This study focused on how artificial intelligence (AI) can help predict how well people with epilepsy will respond to their first two antiseizure medications (ASMs).
This study looked at how the glymphatic system, which helps clear waste from the brain, functions in different types of temporal lobe epilepsy (TLE).
This study looked at children with epilepsy and movement disorders, known as EPIMDs, to better understand their genetic causes and how these conditions present.